Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 134, Issue 3, 357-361
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vihko, K.
Right arrow Articles by Punnonen, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vihko, K.
Right arrow Articles by Punnonen, R

Articles

Gonadotropins and gonadotropin receptors during the perimenopause

KK Vihko, E Kujansuu, P Morsky, I Huhtaniemi, and R Punnonen

Medical School, Department of Obstetrics and Gynecology, Tampere University Hospital, Finland.

Twenty-two perimenopausal patients (aged 47-56 years) admitted for elective abdominal hysterectomy and salpingo-oophorectomy were selected to understand better the clinical significance of increasing gonadotropin levels as an indicator of target organ responsiveness. Prior to anesthesia, blood was drawn from the patients for subsequent analyses of serum follicle-stimulating hormone (FSH), luteinizing hormone (LH) and 17beta-estradiol (E2) levels. Ovarian tissue was obtained during surgery and frozen at -70 degrees C for subsequent analyses for FSH and LH receptor content. The phase of the menstrual cycle of the patients or postmenopause was determined by serum gonadotropin and E2 levels and histological evaluation of the endometrium. Patients with no detectable FSH receptors showed significantly higher serum FSH and LH levels (4.7- and 4.3-fold, respectively) when compared to patients with detectable FSH receptors; FSH receptors were present in 27% of the patients, LH receptors were present in 68% of the patients and a negative correlation was found between serum LH levels and ovarian LH receptors. In postmenopausal patients, neither FSH receptors nor LH receptors were detectable. High serum gonadotropin levels in perimenopausal patients thus suggest the existence of low or undetectable ovarian gonadotropin receptor levels.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
S. J. Park, L. T. Goldsmith, and G. Weiss
Age-Related Changes in the Regulation of Luteinizing Hormone Secretion by Estrogen in Women
Experimental Biology and Medicine, July 1, 2002; 227(7): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Couzinet, G. Meduri, M. G. Lecce, J. Young, S. Brailly, H. Loosfelt, E. Milgrom, and G. Schaison
The Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5060 - 5066.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Simoni, J. Gromoll, and E. Nieschlag
The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology
Endocr. Rev., December 1, 1997; 18(6): 739 - 773.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.